GlaxoSmithKline Pharmaceuticals, incorporated in the year 1924, is a Large Cap company (having a market cap of Rs 21043.62 Crore) operating in Pharmaceuticals sector.
GlaxoSmithKline Pharmaceuticals key Products/Revenue Segments include Pharmaceuticals, Other Operating Revenue and Service Income for the year ending 31-Mar-2022.
Financials
The company’s top management includes Ms.R S Karnad, Mr.Sridhar Venkatesh, Dr.(Ms.)S Maheshwari, Mr.S Williams, Mr.P V Bhide, Mr.A N Roy, Mr.D Sundaram, Mr.M Anand, Mr.J Chandy. Company has Deloitte Haskins & Sells LLP as its auditors. As on 31-12-2022, the company has a total of 17 Crore shares outstanding.
Investment Rationale
In the brokerage's view, higher interest rates have started dampening the demand for mortgages. The brokerage models an advances/PAT CAGR of 11%/26% over FY23-25 foran RoA/RoE of 1.2%/13% in FY25, respectively. Reiterate BUY with a TP ofINR440 (premised on 0.8x Sep’24E P/BV).
Promoter/FII Holdings
Promoters held 75 per cent stake in the company as of 31-Dec-2022, while FIIs owned 2.28 per cent, DIIs 10.27 per cent.
Download The Economic Times News App to get Daily Market Updates & Live Business News.
Subscribe to The Economic Times Prime and read the Economic Times ePaper Online.and Sensex Today.
Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price
Read More News on
Download The Economic Times News App to get Daily Market Updates & Live Business News.
Subscribe to The Economic Times Prime and read the Economic Times ePaper Online.and Sensex Today.
Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price